Greif, Inc. Free Cash Flow 2008–2025
Greif, Inc. reported $0 of free cash flow for fiscal 2025. That was 100.0% lower than fiscal 2024. Compared with fiscal 2020, the change was -100.0%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $0 | -100.0% |
| FY 2024 | $356.00M | -45.2% |
| FY 2023 | $649.50M | -1.2% |
| FY 2022 | $657.50M | +66.0% |
| FY 2021 | $396.00M | -12.9% |
| FY 2020 | $454.70M | +95.4% |
| FY 2019 | $232.70M | +106.3% |
| FY 2018 | $112.80M | -45.8% |
| FY 2017 | $208.20M | +3.6% |
| FY 2016 | $200.90M | +185.0% |
| FY 2015 | $70.50M | -43.1% |
| FY 2014 | $123.90M | +8.8% |
| FY 2013 | $113.90M | -62.9% |
| FY 2012 | $307.30M | +3035.7% |
| FY 2011 | $9.80M | -71.2% |
| FY 2010 | $34.00M | -76.0% |
| FY 2009 | $141.85M | +4476.8% |
| FY 2008 | $-3.24M | — |
Source: Greif, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open GEF 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Greif, Inc. reported $0 of free cash flow for fiscal 2025. That was 100.0% lower than fiscal 2024. Compared with fiscal 2020, the change was -100.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Greif, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeGreif, Inc. — frequently asked questions
What is Greif, Inc.'s free cash flow?
Greif, Inc. (GEF) reported free cash flow of $0 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Greif, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.